Crystal Structures and Structure Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors

被引:122
|
作者
Tojo, Shingo [1 ]
Kohno, Tetsuya [1 ]
Tanaka, Tomoyuki [1 ]
Kamioka, Seiji [1 ]
Ota, Yosuke [1 ]
Ishii, Takayuki [1 ]
Kamimoto, Keiko [1 ]
Asano, Shigehiro [1 ]
Isobe, Yoshiaki [1 ]
机构
[1] Dainippon Sumitomo Pharma Co Ltd, Konohana Ku, Osaka 5540022, Japan
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2014年 / 5卷 / 10期
关键词
Indoleamine 2,3-dioxygenagse 1; crystal structure; induced fit; structure-based drug discovery; imidazothiazole; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN; TOLERANCE; DESIGN;
D O I
10.1021/ml500247w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure activity relationships (SAR) at the pocket-B of IDO I, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDOI activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.
引用
收藏
页码:1119 / 1123
页数:5
相关论文
共 50 条
  • [31] A new series of IDO1 inhibitors derived from microbial metabolites
    Zhu, Jingtong
    Yu, Man
    Shen, Wenbin
    Ren, Xiao
    Zheng, Haizhou
    Mu, Yunlong
    Lu, Xinhua
    Zhai, Lili
    PHYTOCHEMISTRY LETTERS, 2023, 54 : 76 - 80
  • [32] Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies
    Jiang, Kehua
    Wang, Qing
    Chen, Xiao-Long
    Wang, Xiaodong
    Gu, Xiaoya
    Feng, Shuangshuang
    Wu, Jian
    Shang, Haojie
    Ba, Xiaozhuo
    Zhang, Yanlong
    Tang, Kun
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 8847 - 8882
  • [33] Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
    Serafini, Marta
    Torre, Enza
    Aprile, Silvio
    Del Grosso, Erika
    Gesu, Alessandro
    Griglio, Alessia
    Colombo, Giorgia
    Travelli, Cristina
    Paiella, Salvatore
    Adamo, Annalisa
    Orecchini, Elena
    Coletti, Alice
    Pallotta, Maria Teresa
    Ugel, Stefano
    Massarotti, Alberto
    Pirali, Tracey
    Fallarini, Silvia
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) : 3047 - 3065
  • [34] Quantification of IDO1 enzyme activity in normal and malignant tissues
    Zhai, Lijie
    Ladomersky, Erik
    Bell, April
    Dussold, Corey
    Cardoza, Krislyn
    Qian, Jun
    Lauing, Kristen L.
    Wainwright, Derek A.
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - MOLECULAR METHODS, 2019, 629 : 235 - 256
  • [35] Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays
    Huizhen Ge
    Longfei Mao
    Jie Zhao
    Yuwei Wang
    Danfeng Shi
    Xing Yang
    Xiaorui Wang
    Huanxiang Liu
    Xiaojun Yao
    Journal of Computer-Aided Molecular Design, 2021, 35 : 679 - 694
  • [36] Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays
    Ge, Huizhen
    Mao, Longfei
    Zhao, Jie
    Wang, Yuwei
    Shi, Danfeng
    Yang, Xing
    Wang, Xiaorui
    Liu, Huanxiang
    Yao, Xiaojun
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2021, 35 (05) : 679 - 694
  • [37] Synergistic Antitumor Efficacy of an Inhibitor of IDO1 and Cytotoxic Agents Which Induce IDO Activity
    Koblish, Holly K.
    Hansbury, Michael J.
    Bowman, Kevin J.
    Kelley, Jennifer A.
    Brown, Ryan
    Wayland, Brian
    Yue, Eddy W.
    Combs, Andrew P.
    Scherle, Peggy A.
    Fridman, Jordan S.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (02) : 223 - 223
  • [38] Prediction of IDO1 Inhibitors by a Fingerprint-Based Stacking Ensemble Model Named IDO1Stack
    Sun, Huimin
    Yang, Qing
    Yu, Xinxin
    Huang, Mengting
    Ding, Meng
    Li, Weihua
    Tang, Yun
    Liu, Guixia
    CHEMMEDCHEM, 2023, 18 (17)
  • [39] Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
    Roehrig, Ute F.
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Reynaud, Aline
    Pojer, Florence
    Dilek, Nahzli
    Reichenbach, Patrick
    Ascencao, Kelly
    Irving, Melita
    Coukos, George
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 1773 - 1811
  • [40] Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Roehrig, Ute F.
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Zoete, Vincent
    Michiein, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9421 - 9437